Dr.Finance S.A. (WSE:DRF)
Poland flag Poland · Delayed Price · Currency is PLN
1.130
+0.230 (25.56%)
At close: Sep 12, 2025

Dr.Finance Statistics

Total Valuation

Dr.Finance has a market cap or net worth of PLN 4.23 million. The enterprise value is 3.92 million.

Market Cap4.23M
Enterprise Value 3.92M

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date Nov 14, 2025
Ex-Dividend Date n/a

Share Statistics

Dr.Finance has 3.74 million shares outstanding.

Current Share Class 3.74M
Shares Outstanding 3.74M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 42.32%
Owned by Institutions (%) n/a
Float 1.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.44
PB Ratio 13.17
P/TBV Ratio 13.17
P/FCF Ratio n/a
P/OCF Ratio 68.82
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -183.71
EV / Sales 0.41
EV / EBITDA 92.22
EV / EBIT 94.55
EV / FCF n/a

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.29.

Current Ratio 2.29
Quick Ratio 1.88
Debt / Equity 0.29
Debt / EBITDA 2.15
Debt / FCF n/a
Interest Coverage 18.56

Financial Efficiency

Return on equity (ROE) is -6.33% and return on invested capital (ROIC) is 6.77%.

Return on Equity (ROE) -6.33%
Return on Assets (ROA) 4.66%
Return on Invested Capital (ROIC) 6.77%
Return on Capital Employed (ROCE) 12.92%
Revenue Per Employee 9.54M
Profits Per Employee -21,344
Employee Count1
Asset Turnover 17.15
Inventory Turnover 2.40

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +43.04% in the last 52 weeks. The beta is 1.38, so Dr.Finance's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change +43.04%
50-Day Moving Average 0.85
200-Day Moving Average 0.75
Relative Strength Index (RSI) 64.09
Average Volume (20 Days) 14,232

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Dr.Finance had revenue of PLN 9.54 million and -21,344 in losses. Loss per share was -0.01.

Revenue9.54M
Gross Profit 9.23M
Operating Income 41,469
Pretax Income -21,344
Net Income -21,344
EBITDA 42,516
EBIT 41,469
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 396,500 in cash and 91,500 in debt, giving a net cash position of 305,000 or 0.08 per share.

Cash & Cash Equivalents 396,500
Total Debt 91,500
Net Cash 305,000
Net Cash Per Share 0.08
Equity (Book Value) 320,900
Book Value Per Share 0.09
Working Capital 320,700
Full Balance Sheet

Cash Flow

Operating Cash Flow 61,404
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 96.74%, with operating and profit margins of 0.43% and -0.22%.

Gross Margin 96.74%
Operating Margin 0.43%
Pretax Margin -0.22%
Profit Margin -0.22%
EBITDA Margin 0.45%
EBIT Margin 0.43%
FCF Margin n/a

Dividends & Yields

Dr.Finance does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -0.51%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 1, 2016. It was a reverse split with a ratio of 0.01.

Last Split Date Jul 1, 2016
Split Type Reverse
Split Ratio 0.01

Scores

Dr.Finance has an Altman Z-Score of 14.5 and a Piotroski F-Score of 5.

Altman Z-Score 14.5
Piotroski F-Score 5